Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1703 of 5804
-
Experimental vaccine trains immune system to attack kidney tumors
Disease control CompletedThe main purpose of this study is to test the safety of the dendritic cell/tumor fusion study vaccine in combination with a laboratory-made agent called Granulocyte Macrophage Colony Stimulating Factor (GM-CSF). Another purpose is to determine the type and severity of any side ef…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Drug that starves tumors shows promise against advanced kidney cancer
Disease control CompletedRATIONALE: Lenalidomide may stop the growth of kidney cancer by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well lenalidomide works in treating patients with advanced or unresectable kidney cancer.
Phase: PHASE2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a targeted drug shrink recurrent endometrial tumors?
Disease control CompletedThe goal of this clinical research study is to learn if RAD001 can shrink or slow the growth of tumors in patients who have recurrent endometrial cancer. The safety of this drug will also be studied. Objectives: Primary Objective: 1\. To determine the efficacy of RAD001 in pat…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Immune cell infusion shows promise against post-transplant blood cancer relapse
Disease control CompletedThis is a phase 1 dose escalation study evaluating the use of activated T-cells to treat relapsed malignancy (cancer) following allogeneic hematopoietic cell transplantation, without causing GvHD.
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New oral drug cocktail shows promise for kids with resistant neuroblastoma
Disease control CompletedRATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die. Temozolomide may help irinotecan kill more tumor cells by making them more sensitive to the drug. Cefixime may be effe…
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New asthma pill shows promise in major trial
Disease control CompletedThe aim of the study is to investigate the effect of roflumilast (APTA-2217) on lung function in patients with asthma. Roflumilast will be administered orally once daily. The study duration consists of a baseline period (2 to 4 weeks) and a treatment period (24 weeks). The study …
Phase: PHASE2, PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThe purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Experimental drug RAD001 tested for tough leukemias and lymphomas
Disease control CompletedThe goal of this clinical research study is to find the highest safe dose of RAD001 that can be given as a treatment for leukemia, mantle cell lymphoma, or myelofibrosis. Another goal is to learn how effective the dose that is found is as a treatment.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Switching transplant drug may cut skin cancer risk
Disease control CompletedIn a population of kidney transplant recipients having developed a first squamous cell carcinoma, the aim of the study is to assess the incidence of subsequent skin cancers over 2 years in patients who are switched to rapamycin as compared to patients who are maintained under cal…
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Simple vitamin pills could cut blood transfusions in pregnant african women
Prevention CompletedThe purpose of this research is to compare the efficacy of two low-cost low intervention packages to prevent and treat severe anemia in pregnant women in Zanzibar, Tanzania. The two packages are Standard of Care as described by the WHO (presumptive treatment for malaria and helmi…
Phase: PHASE3 • Sponsor: Cornell University • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Radiation showdown: which schedule beats childhood brain cancer?
Disease control CompletedThis is an international prospective randomised trial, which will compare two radiotherapy regimens in children and adolescents (aged 4 or 5 years to 21 years inclusive) with carefully staged 'standard risk' medulloblastoma.
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 26, 2026 17:03 UTC
-
New drug combo shows promise for rare penile cancer
Disease control CompletedThe purpose of this study is to determine whether association Gemcitabine-Cisplatin is effective in the treatment of penis epidermoid carcinoma loco-regionally advanced or metastatic.
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThe goal of this clinical research study is to learn if giving the new drug, Tarceva® (OSI-774), in combination with Platinol® (cisplatin) and Taxotere® (docetaxel) is effective in the treatment of metastatic or recurrent head and neck cancer. The safety of this treatment will al…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can heat zapping stop esophagus cancer before it starts?
Disease control ENROLLING_BY_INVITATIONTo assess the effect of ablative therapy (Photodynamic Therapy or Radiofrequency ablation ) on Barrett's Esophagus
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Gene expression platform could revolutionize kidney transplant rejection diagnosis
Knowledge-focused CompletedThis retrospective multicentre observational study developed and validated HistoMX, an automated gene-expression-based platform for multidimensional molecular interpretation of kidney allograft biopsies. The study included 2,410 archived post-transplant kidney allograft biopsy s…
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Heart scan study aims to predict sudden death before it strikes
Knowledge-focused Recruiting nowSudden cardiac death is a tragic event that strikes all age groups and is unfortunately increasing in prevalence. Because it is difficult to predict those at highest risk, this study is designed to test the hypothesis that new imaging techniques (magnetic resonance imaging \[MRI\…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Heat therapy for lung tumors: a new option for inoperable patients?
Disease control TerminatedThe purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing …
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Prostate cancer radiation showdown: does adding external beam help?
Disease control CompletedRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Interstitial brachytherapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Combining interstitial brachytherapy with external-beam radiation therapy m…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Chemo cocktail takes on rare bladder cancers
Disease control OngoingRATIONALE: Drugs used in chemotherapy, such as fluorouracil, leucovorin, gemcitabine, and cisplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase II trial is stud…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 15:14 UTC
-
New drug cocktail plus radiation shows promise against esophageal cancer
Disease control CompletedThe standard non surgical therapy of locally advanced esophageal cancer is based on a definitive concurrent chemoradiotherapy regimen with fluorouracil and cisplatin. One of the alternative regimen which is being studied is the combination of a weekly cisplatin and irinotecan sch…
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC